AdaptOS™ Atlas Vertical: AI in Medical Devices - Therapeutic Devices 2026

From signal to reimbursement: closed-loop personalization, recall prevention, documentation synthesis, safety gating, and supply resilience — 40 pilot-ready solutions.

Therapeutic device makers compete on outcome efficacy, regulatory velocity, and margin discipline. This pack tackles lab-to-life operations: adaptive therapy tuning, implant fit/configuration, on-device coaching and adherence, MDR/PMCF automation, multimodal claims QA, reimbursement optimization, OR workflow and territory planning, cybersecurity for connected fleets, and post-market surveillance with early recall flags. Built for CMOs, RA/QA leaders, Clinical Engineering, Product, and CFOs, it moves organizations from reactive troubleshooting to predictive, explainable, and audit-ready device development, deployment, and support.

What you get: 40 solutions mapped to the AdaptOS™ Atlas locked schema to align AI adoption with your current tech stack—segment shifts, strategic imperatives, adoption sequencing, solution clusters, value-compounding paths, governance & trust anchors, risk & resistance playbooks, board-level guardrails, RFP-ready vendor-analog references (non-endorsement), KPI-anchored 90-day pilots, buyer personas, HITL boundaries, and integration/data/security notes—so you can sequence action and defend spend with evidence in 2026.